Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | CES2 | O00748 | 2/20 | 0.34 |
| ▸ | CES1 | P23141 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | PKM | P14618 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 2/20 | 0.31 |
| ▸ | ATM | Q13315 | 2/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2680684 | 0.80 | MAPT (0.41) | ALDH1A1LMNACES2CES1SMN1; SMN2 | |
| SCHEMBL1869090 | 0.80 | ALDH1A1 (0.50) | ALDH1A1CES2CES1SMN1; SMN2TDP1 | |
| SCHEMBL11145825 | 0.78 | PARP10 (0.42) | ALDH1A1SMN1; SMN2TDP1KMT2A | |
| SCHEMBL3278080 | 0.75 | PGR (0.34) | ALDH1A1LMNACES2CES1SMN1; SMN2 | |
| SCHEMBL28030580 | 0.75 | HDAC8 (0.50) | ALDH1A1SMN1; SMN2HTTHPGDGAA | |
| SCHEMBL1459630 | 0.75 | TDP1 (0.55) | ALDH1A1LMNASMN1; SMN2HTTATM | |
| SCHEMBL2233870 | 0.72 | CA1 (0.56) | ALDH1A1LMNASMN1; SMN2HTTNPSR1 | |
| SCHEMBL9901799 | 0.71 | CA12 (0.42) | ALDH1A1LMNAHPGDMEN1KMT2A | |
| SCHEMBL5609868 | 0.69 | ALDH1A1 (0.62) | ALDH1A1LMNACES2CES1SMN1; SMN2 | |
| SCHEMBL2237100 | 0.69 | RAB9A (0.53) | LMNASMN1; SMN2HPGDMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0205077-A2 | Suramin sodium for use as an immunostimulant | BAYER AG (DE) | 1986-12-17 | — | — | EP | claimed |
| CN-110073005-A | Method for detecting norovirus | 奎斯特诊断投资有限责任公司 | 2019-07-30 | — | — | CN | disclosed |
| EP-1487432-B1 | SURAMIN AND DERIVATIVES THEREOF AS TOPICAL MICROBICIDE AND CONTRACEPTIVE | EASTERN VIRGINIA MED SCHOOL (US) | 2013-03-06 | — | — | EP | disclosed |
| EP-1487432-A4 | SURAMIN AND DERIVATIVES THEREOF AS TOPICAL MICROBICIDE AND CONTRACEPTIVE | EASTERN VIRGINIA MED SCHOOL (US) | 2008-06-25 | — | — | EP | disclosed |
| EP-1487432-A2 | SURAMIN AND DERIVATIVES THEREOF AS TOPICAL MICROBICIDE AND CONTRACEPTIVE | Eastern Virginia Medical School (US) | 2004-12-22 | — | — | EP | disclosed |
| WO-2003082193-A2 | SURAMIN AND DERIVATIVES THEREOF AS TOPICAL MICROBICIDE AND CONTRACEPTIVE | EASTERN VIRGINIA MEDICAL SCHOOL (US) | 2003-10-09 | — | — | WO | disclosed |
| US-20020152629-A1 | Process for removing trace solvent from a material | PFIZER SCIENCE AND TECHNOLOGY IRELAND LIMITED (IE) | 2002-10-24 | — | — | US | disclosed |
| EP-0711163-B1 | USE OF BENZYDAMINE IN THE TREATMENT OF PATHOLOGICAL CONDITIONS CAUSED BY TNF | AZIENDE CHIMICHE RIUNITE BR AN (IT) | 2001-10-24 | — | — | EP | disclosed |
| US-6300358-B1 | ADMINISTERING BENZYDAMINE OR A PHYSIOLOGICALLY ACCEPTABLE ACID ADDITION SALT FOR THERAPY OF CONDITION CAUSED BY TUMOR NECROSIS FACTOR | ANGELINI RICERCHE S.P.A. SOCIETA'CONSORTILE (IT) | 2001-10-09 | — | — | US | disclosed |
| EP-0486809-A2 | Use of suramin against TNF-related diseases | FARMITALIA CARLO ERBA S.r.l. (IT) | 1992-05-27 | — | — | EP | disclosed |